特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
823179

プロテオミクスの世界市場の将来予測

Global Proteomics Market Forecast 2019-2027

出版日: | 発行: Inkwood Research | ページ情報: 英文 170 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.64円
プロテオミクスの世界市場の将来予測
出版日: 2019年04月15日
発行: Inkwood Research
ページ情報: 英文 170 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界プロテオミクス市場の将来展望について分析し、主な市場促進・抑制要因や、全体的な市場動向の見通し (今後9年間分)、用途別・コンポーネント別・エンドユーザー別および地域別の詳細動向、市場の競争環境および求心力、各国政府の関連規制・政策、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場のダイナミクス

  • 市場の範囲と定義
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 用途別の市場

  • 創薬
  • 疾患診断
  • その他の用途

第6章 コンポーネント別の市場

  • 試薬
    • マイクロアレイ
    • 分光法
    • X線結晶分析
    • クロマトグラフィー
    • 電気泳動
    • イムノアッセイ
    • タンパク質分画試薬
  • 分析装置
    • マイクロアレイ
    • 分光法
      • 質量分析法
      • NMR (核磁気共鳴反応) スペクトル分析
    • クロマトグラフィー
      • 高速液体クロマトグラフィー (HPLC) システム
      • イオン交換クロマトグラフィー
      • アフィニティークロマトグラフィー
      • 超臨界流体クロマトグラフィー
  • サービス

第7章 エンドユーザー別の市場

  • 創薬 (新薬発見・医薬開発)
  • 応用研究
  • 基礎研究
  • 診断

第8章 主な分析指標

  • ポーターのファイブフォース分析
    • 新規参入企業の脅威
    • 代替製品の脅威
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 企業間競争
  • プロテオミクス産業の分析
  • 創薬分野におけるプロテオミクスの活用
  • プロテオミクスにおける科学的な取り組み
  • 特許分析
  • 市場機会マトリックス

第9章 地域別分析

  • 北米市場 (米国、カナダ)
  • 欧州市場 (ドイツ、フランス、英国、イタリア、スペインなど)
  • アジア太平洋地域市場 (日本、中国、インド、オーストラリア、韓国など)
  • 他の国々の市場 (RoW:ラテンアメリカ、中東・アフリカ)

第10章 競争環境

  • 市場ポジショニング分析
  • 企業プロファイル
    • AGILENT TECHNOLOGIES, INC.
    • BIO-RAD LABORATORIES, INC.
    • BRUKER CORPORATION
    • CAPRION BIOSCIENCES (GHO CAPITALが買収済み)
    • DANAHER CORPORATION
    • GENERAL ELECTRIC COMPANY
    • GLAXOSMITHKLINE
    • 堀場製作所
    • LI-COR INC.
    • LUMINEX CORP.
    • MERCK & COMPANY INC.
    • PERKINELMER, INC.
    • QIAGEN N.V.
    • THERMO FISHER SCIENTIFIC INC.
    • WATERS CORPORATION
目次
Product Code: 24604

KEY FINDINGS

Proteomics is the large scale study of overall protein content in any biological system. It involves the applications of technologies for the identi?cation and quanti?cation of overall proteins present content of a cell, tissue or an organism. The research market for proteomics has been the main focus of proteomics products, which has resulted in strong growth. The proteomics market, however, is shifting toward applied end markets, including drug discovery and development and applied laboratories.

The global proteomics is estimated to grow from $XX billion in 2018 to $58.3 billion by 2027, at a CAGR of 14.68% between 2019 and 2027.

MARKET INSIGHTS

Advancements in technologies such as mass spectrometry and chromatography and development of computer algorithms for database searching facilitate proteomics research. The increase in popularity of personalized medicines is expected to propel the market. However, the high cost of instruments and dearth of skilled researchers hamper market growth.

Proteomics information can complement genomics data to help drug researchers better understand how the underlying biologics of system function. The applications and components of the proteomics market are used extensively for various purposes. Proteomics is used for the discovery of new antimalarial drugs that target purine-binding proteins in the blood stage of infection.

REGIONAL INSIGHTS

Geographically, the global proteomics device market has been segmented based on four major regions, which are North America, Europe, Asia Pacific and the remaining countries collectively termed as the Rest of World regional segment.

The proteomics market in North America is expected to hold the largest share by 2027 possibilities of increased use of proteomics, which constitutes approximately 40% of the market share. The U.S. proteomics market is expected to account for the majority of the share in the global market. However, the proteomics research received a major boost in Canada, owing to the funding support by a government organization.

COMPETITIVE INSIGHTS

Qiagen N.V., Waters Corporation, LI-COR Inc., General Electric Company, Luminex Corp., Horiba, Ltd., GlaxoSmithKline, Caprion Biosciences (acquired by GHO Capital), Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Merck & Company Inc., Danaher Corporation, Bruker Corporation, and Agilent Technologies, Inc. are the major companies operating in the global market that have been profiled extensively in the report. Most of these companies are looking for strategies such as merger & acquisition, partnership, contracts, agreements, & new product launch, to gain a competitive edge over other companies by further expansion.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REAGENTS ARE THE WIDELY USED PROTEOMICS COMPONENT
    • 3.2.2. DISEASE DIAGNOSIS IS THE FASTEST GROWING APPLICATION
    • 3.2.3. DRUG DISCOVERY AND DEVELOPMENT IS THE MAJORLY USED END-USER

4. MARKET DETERMINANTS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. ADVANCEMENT IN PROTEOMIC TECHNOLOGIES
    • 4.2.2. INCREASE IN R&D EXPENDITURE
    • 4.2.3. TECHNOLOGICAL ADVANCEMENTS
    • 4.2.4. INCREASING USE OF PROTEOMICS INFORMATION
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF INSTRUMENTS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. IDENTIFICATION OF NOVEL BIOMARKERS
    • 4.4.2. WIDESPREAD USE OF MASS SPECTROMETER TO STUDY PROTEIN-PROTEIN INTERACTION
  • 4.5. MARKET CHALLENGES
    • 4.5.1. LACK OF SKILLED PROFESSIONALS
    • 4.5.2. STRINGENT REGULATIONS

5. MARKET BY APPLICATION

  • 5.1. DRUG DISCOVERY
  • 5.2. DISEASE DIAGNOSIS
  • 5.3. OTHER APPLICATION

6. MARKET BY COMPONENT

  • 6.1. REAGENTS
    • 6.1.1. MICROARRAY
    • 6.1.2. SPECTROSCOPY
    • 6.1.3. X-RAY CRYSTALLOGRAPHY
    • 6.1.4. CHROMATOGRAPHY
    • 6.1.5. ELECTROPHORESIS
    • 6.1.6. IMMUNOASSAY
    • 6.1.7. PROTEIN FRACTIONATION REAGENTS
  • 6.2. INSTRUMENTS
    • 6.2.1. MICROARRAY
    • 6.2.2. SPECTROSCOPY
      • 6.2.2.1. MASS SPECTROMETRY
      • 6.2.2.2. NMR SPECTROMETRY
    • 6.2.3. CHROMATOGRAPHY
      • 6.2.3.1. HPLC SYSTEMS
      • 6.2.3.2. ION CHROMATOGRAPHY
      • 6.2.3.3. AFFINITY CHROMATOGRAPHY
      • 6.2.3.4. SUPERCRITICAL FLUID CHROMATOGRAPHY
  • 6.3. SERVICES

7. MARKET BY END-USER

  • 7.1. DRUG DISCOVERY AND DEVELOPMENT
  • 7.2. APPLIED
  • 7.3. RESEARCH
  • 7.4. DIAGNOSTICS

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE
    • 8.1.3. BARGAINING POWER OF BUYERS
    • 8.1.4. BARGAINING POWER OF SUPPLIERS
    • 8.1.5. THREAT OF COMPETITIVE RIVALRY
  • 8.2. PROTEOMICS INDUSTRY ANALYSIS
  • 8.3. APPLICATIONS OF PROTEOMIC IN DRUG DISCOVERY AND DEVELOPMENT
  • 8.4. SCIENTIFIC INITIATIVES IN PROTEOMICS
  • 8.5. PATENT ANALYSIS
  • 8.6. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. JAPAN
    • 9.3.2. CHINA
    • 9.3.3. INDIA
    • 9.3.4. AUSTRALIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. REST OF ASIA-PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET POSITION ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. AGILENT TECHNOLOGIES, INC.
    • 10.2.2. BIO-RAD LABORATORIES, INC.
    • 10.2.3. BRUKER CORPORATION
    • 10.2.4. CAPRION BIOSCIENCES (ACQUIRED BY GHO CAPITAL)
    • 10.2.5. DANAHER CORPORATION
    • 10.2.6. GENERAL ELECTRIC COMPANY
    • 10.2.7. GLAXOSMITHKLINE
    • 10.2.8. HORIBA, LTD.
    • 10.2.9. LI-COR INC.
    • 10.2.10. LUMINEX CORP.
    • 10.2.11. MERCK & COMPANY INC.
    • 10.2.12. PERKINELMER, INC.
    • 10.2.13. QIAGEN N.V.
    • 10.2.14. THERMO FISHER SCIENTIFIC INC.
    • 10.2.15. WATERS CORPORATION

TABLES LIST

  • TABLE 1 GLOBAL PROTEOMICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 GLOBAL PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 3 GLOBAL DRUG DISCOVERY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL DISEASE DIAGNOSIS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL OTHER APPLICATION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL REAGENTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL REAGENTS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL INSTRUMENTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL INSTRUMENTS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 11 GENERAL WORKFLOW OF MASS SPECTROMETRY (MS)
  • TABLE 12 GLOBAL SERVICES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL PROTEOMICS MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY BIOCHIP PLATFORM 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL RESEARCH MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL BIOCHIP MARKET BY PLATFORM 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL DIAGNOSTICS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL BIOCHIP MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL DIAGNOSTICS MARKET BY DISEASE TYPE 2019-2027 ($ MILLION)
  • TABLE 21 GLOBAL DISEASE TYPE MARKET BY CANCER 2019-2027 ($ MILLION)
  • TABLE 22 STATUS OF THE MAJOR PROTEOMICS INDUSTRIES
  • TABLE 23 ARRAY-RELATED PROTEOMICS PATENTS BY REGION 2015-2018 (%)
  • TABLE 24 LOC-RELATED PROTEOMICS PATENTS BY REGION 2015-2018 (%)
  • TABLE 25 MASS SPECTROMETRY-RELATED PROTEOMICS PATENTS BY REGION 2015-2018 (%)
  • TABLE 26 GLOBAL PROTEOMICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 27 NORTH AMERICA PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 28 THE UNITED STATES PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 29 THE UNITED STATES PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 30 CANADA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 31 CANADA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 32 EUROPE PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 33 GERMANY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 34 GERMANY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 35 FRANCE PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 36 FRANCE PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 37 THE UNITED KINGDOM PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 38 THE UNITED KINGDOM PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 39 ITALY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 40 ITALY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 41 SPAIN PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 42 SPAIN PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 43 ASIA PACIFIC PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 44 JAPAN PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 45 JAPAN PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 46 CHINA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 47 CHINA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 48 INDIA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 49 INDIA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 50 AUSTRALIA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 51 AUSTRALIA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 52 SOUTH KOREA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 53 SOUTH KOREA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 54 REST OF WORLD PROTEOMICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 55 PROTEOMICS COMPANY MARKET POSITION ANALYSIS 2017

FIGURES LIST

  • FIGURE 1 GLOBAL PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL PROTEOMICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 3 GLOBAL PROTEOMICS MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)
  • FIGURE 4 GLOBAL PROTEOMICS MARKET BY DISEASE DIAGNOSIS 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL PROTEOMICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL PROTEOMICS MARKET SHARE BY COMPONENT 2018 & 2027 (%)
  • FIGURE 7 GLOBAL PROTEOMICS MARKET BY REAGENTS 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL REAGENTS MARKET BY MICROARRAY 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL REAGENTS MARKET BY SPECTROSCOPY 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL REAGENTS MARKET BY X-RAY CRYSTALLOGRAPHY 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL REAGENTS MARKET BY CHROMATOGRAPHY 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL REAGENTS MARKET BY ELECTROPHORESIS 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL REAGENTS MARKET BY IMMUNOASSAY 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL REAGENTS MARKET BY PROTEIN FRACTIONATION REAGENTS 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL PROTEOMICS MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)
  • FIGURE 16 GLOBAL INSTRUMENTS MARKET BY MICROARRAY 2019-2027 ($ MILLION)
  • FIGURE 17 GLOBAL INSTRUMENTS MARKET BY SPECTROSCOPY 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL SPECTROSCOPY MARKET BY MASS SPECTROMETRY 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL SPECTROSCOPY MARKET BY NMR SPECTROMETRY 2019-2027 ($ MILLION)
  • FIGURE 20 GLOBAL INSTRUMENTS MARKET BY CHROMATOGRAPHY 2019-2027 ($ MILLION)
  • FIGURE 21 GLOBAL CHROMATOGRAPHY MARKET BY HPLC SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 22 GLOBAL CHROMATOGRAPHY MARKET BY ION CHROMATOGRAPHY 2019-2027 ($ MILLION)
  • FIGURE 23 GLOBAL CHROMATOGRAPHY MARKET BY AFFINITY CHROMATOGRAPHY 2019-2027 ($ MILLION)
  • FIGURE 24 GLOBAL CHROMATOGRAPHY MARKET BY SUPERCRITICAL FLUID CHROMATOGRAPHY 2019-2027 ($ MILLION)
  • FIGURE 25 GLOBAL PROTEOMICS MARKET BY SERVICES 2019-2027 ($ MILLION)
  • FIGURE 26 GLOBAL PROTEOMICS MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 27 GLOBAL PROTEOMICS MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2019-2027 ($ MILLION)
  • FIGURE 28 GLOBAL PROTEOMICS MARKET BY APPLIED 2019-2027 ($ MILLION)
  • FIGURE 29 GLOBAL PROTEOMICS MARKET BY RESEARCH 2019-2027 ($ MILLION)
  • FIGURE 30 GLOBAL PROTEOMICS MARKET BY DIAGNOSTICS 2019-2027 ($ MILLION)
  • FIGURE 31 PORTER'S FIVE FORCE MODEL
  • FIGURE 32 GLOBAL PROTEOMICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 33 THE UNITED STATES PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 CANADA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 35 GERMANY PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 36 FRANCE PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 37 THE UNITED KINGDOM PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 38 ITALY PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 SPAIN PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 REST OF EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 41 JAPAN PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 CHINA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 INDIA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 44 AUSTRALIA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 45 SOUTH KOREA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 46 REST OF ASIA-PACIFIC PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 47 LATIN AMERICA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 48 MIDDLE EAST AND AFRICA PROTEOMICS MARKET 2019-2027 ($ MILLION)
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.